Update announcement regarding Presmed Australia's investment in DEVOCLEA ADVANCED HEALTH LIMITED (Incorporated in the Republic of South Africa) (Registration number 2013/059246/06) (“the Company” or “Advanced Health”) ISIN Code: ZAE000189049 JSE Code: AVL UPDATE ANNOUNCEMENT REGARDING PRESMED AUSTRALIA’S INVESTMENT IN DEVOCLEA Transaction update Shareholders are referred to the detailed terms and cautionary announcement that was released on SENS on 11 June 2021, regarding Presmed Australia Pty Limited (“PMA”), acquisition of a 20% interest in the Devonport Eye Hospital (NWC) Pty Ltd (“Devonport Eye Hospital”) and Clearvis Pty Ltd (“Clearvis”) (collectively “DEVOCLEA”), (the “Transaction”). Shareholders are advised that not all the conditions precedents were fulfilled or waived as at 30 June 2021 and as a result, the parties have agreed to extend the expected effective date and completion date of the Transaction from 30 June 2021 to 31 July 2021, in terms of the Transaction agreement. Renewal of cautionary announcement As previously advised, the additional Transaction consideration amount will be disclosed in a further SENS announcement, once it has been determined. It has been agreed with the JSE that the disclosure of the profit and net assets attributable to the Transaction may be delayed until the conditions precedents have been fulfilled or waived. Pending the finalisation of the additional Transaction consideration amount and the notification of the profit and net assets attributable to the Transaction, shareholders are advised to continue to exercise caution when dealing in the company’s securities until such further announcement has been released. Johannesburg 30 June 2021 Designated Advisor Grindrod Bank Limited Date: 30-06-2021 12:00:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.